Samples/Biomarkers | CNRIP1 | FBN1 | INA | SNCA | MAL | SPG20 § | Biomarker panel†|
---|---|---|---|---|---|---|---|
Colon Cancer Cell Lines* | 20/20 (100%) | 18/20 (90%) | 19/20 (95%) | 18/20 (90%) | 19/20 (95%) | 20/20 (100%) | 20/20 (100%) |
Adenomas Test Set | 54/60 (90%) | 41/60 (68%) | 25/60 (42%) | 33/60 (55%) | 51/60 (85%) | 45/60 (75%) | 54/60 (90%) |
Adenomas Validation Set | 47/51 (92%) | 36/51 (71%) | 14/51 (27%) | 26/51 (51%) | 42/51 (82%) | 42/51 (82%) | 49/51 (96%) |
Adenomas Combined (Test and Validation Sets) | 101/111 (91%) | 77/111 (69%) | 39/111 (35%) | 59/111 (53%) | 93/111 (84%) | 87/111 (78%) | 103/111 (93%) |
CRC Test Set | 73/74 (99%) | 60/74 (81%) | 49/74 (66%) | 54/74 (73%) | 68/74 (92%) | 67/74 (91%) | 73/74 (99%) |
CRC Validation Set | 96/105 (91%) | 82/105 (78%) | 68/105 (65%) | 65/105 (62%) | 94/105 (90%) | 92/105 (88%) | 95/105 (90%) |
Normal Mucosa Matching CRC Validation Set | 42/105 (40%) | 2/105 (2%) | 0/105 (0%) | 0/105 (0%) | 3/105 (3%) | 0/105 (0%) | 4/105 (4%) |
CRCs Combined (Test and Validation Sets) | 169/179 (94%) | 142/179 (79%) | 117/179 (65%) | 119/179 (66%) | 162/179 (91%) | 159/179 (89%) | 168/179 (94%) |
Normal Mucosa Test Set | 1/51 (2%) | 1/51 (2%) | 0/51 (0%) | 0/51 (0%) | 1/51 (2%) | 1/51 (2%) | 1/51 (2%) |
Normal Mucosa Validation Set | 5/59 (8%) | 0/59 (0%) | 0/59 (0%) | 0/59 (0%) | 1/59 (2%) | 0/59 (0%) | 1/59 (2%) |
Normals Combined (Test and Validation Sets) | 6/110 (5%) | 1/110 (1%) | 0/110 (0%) | 0/110 (0%) | 2/110 (2%) | 1/110 (1%) | 2/110 (2%) |